GALERA THERAPEUTICS INC's ticker is GRTX and the CUSIP is 36338D108. A total of 35 filers reported holding GALERA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4 | -99.8% | 24 | -96.5% | 0.00% | – |
| Q2 2023 | $2,134 | – | 684 | +2750.0% | 0.00% | – |
| Q1 2023 | $0 | – | 24 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 24 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 24 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 24 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 24 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 24 | -52.9% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 51 | -99.9% | 0.00% | – |
| Q2 2021 | $353,000 | +68.9% | 35,973 | +52.1% | 0.00% | – |
| Q1 2021 | $209,000 | -9.5% | 23,654 | +4.8% | 0.00% | – |
| Q4 2020 | $231,000 | +327.8% | 22,564 | +262.1% | 0.00% | – |
| Q3 2020 | $54,000 | +8.0% | 6,232 | -11.8% | 0.00% | – |
| Q2 2020 | $50,000 | +85.2% | 7,064 | +149.8% | 0.00% | – |
| Q1 2020 | $27,000 | -6.9% | 2,828 | +27.4% | 0.00% | – |
| Q4 2019 | $29,000 | – | 2,219 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nan Fung Group Holdings Ltd | 613,223 | $913,702 | 0.63% |
| SECTORAL ASSET MANAGEMENT INC | 1,666,666 | $2,483,332 | 0.48% |
| Sofinnova Investments, Inc. | 3,083,712 | $4,594,731 | 0.27% |
| Novo Holdings A/S | 2,459,021 | $3,663,941 | 0.23% |
| Tekla Capital Management LLC | 898,374 | $1,338,577 | 0.05% |
| Blackstone Inc. | 1,678,984 | $2,501,686 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 187,000 | $278,630 | 0.01% |
| Ensign Peak Advisors, Inc | 151,777 | $226,148 | 0.00% |
| TCI Wealth Advisors, Inc. | 6,162 | $9,181 | 0.00% |
| Tower Research Capital LLC (TRC) | 17,819 | $27 | 0.00% |